Reproductive Freedom for All Nevada Statement on Supreme Court Hearing Oral Arguments on Medication Abortion Case - Reproductive Freedom for All

Formerly NARAL Pro-Choice America

Press Release

Reproductive Freedom for All Nevada Statement on Supreme Court Hearing Oral Arguments on Medication Abortion Case

For Immediate Release: Tuesday, March 26, 2024

Contact: [email protected]

Reproductive Freedom for All Nevada Statement on Supreme Court Hearing Oral Arguments on Medication Abortion Case

Reno, NV — Today, the U.S. Supreme Court will hear oral arguments in anti-abortion extremists’ case to determine whether to impose additional restrictions on mifepristone. While this safe, effective medication remains available for now, if the Court rules in favor of anti-abortion groups, it could roll back abortion access in our country even further by placing extreme and medically unnecessary restrictions on mifepristone in all 50 states—impacting at least 64.5 million people nationwide.

Reproductive Freedom for All Director of Nevada Campaigns, Denise Lopez, released the following statement:

“If the U.S. Supreme Court decides to rule in favor of anti-abortion extremists and restrict mifepristone nationwide, it would have catastrophic effects for people in our state who will face more barriers to accessing the care they need. The vast majority of Nevadans—4 in 5— support the right to abortion, and any decision rolling back access to this safe and effective medication flies in the face of Nevadans’ values. Nevadans have already spoken up once, voting overwhelmingly to lock abortion rights into law in 1990, and they’re ready to do it again. The Supreme Court must rule against this baseless case.”

This baseless case stems from a federal lawsuit filed by the anti-abortion group Alliance for Hippocratic Medicine in a judge-shopped Texas district court challenging the U.S. Food and Drug Administration (FDA) in its decades-old approval of mifepristone, one of the two medications typically used to provide medication abortion care. While the lawsuit sought to revoke the FDA’s approval of mifepristone in an attempt to pull the medication from the shelves nationwide, the Fifth  has previously turned down that challenge and the Supreme Court is instead hearing arguments on whether to reinstate unnecessary restrictions on mifepristone following a federal court’s ruling on the matter.

Medication abortion using mifepristone, which has been used safely for more than two decades, accounts for more than half of all abortion care nationwide and is now even more important in a post-Dobbs world. If it were further restricted throughout the country, it would create more barriers to accessing the most commonly used method of abortion care and miscarriage management. Attacking medication abortion care is the latest attempt to further roll back abortion access nationwide. Anti-abortion groups—and the politicians they bankroll—have ramped up attacks on it as part of their strategy to push access to care entirely out of reach.

Reproductive Freedom for All has been working alongside partners across the reproductive rights, health, and justice movement to collect signatures for the People’s Petition, which advocates for everyone to have access to medication abortion.


For over 50 years, Reproductive Freedom for All (formerly NARAL Pro-Choice America) has fought to protect and advance reproductive freedom at the federal and state levels—including access to abortion care, birth control, pregnancy and post-partum care, and paid family leave—for everybody. Reproductive Freedom for All is powered by its more than 4 million members from every state and congressional district in the country, representing the 8 in 10 Americans who support legal abortion.